RedHill Biopharma (RDHL) Asset Utilization Ratio (2013 - 2023)

RedHill Biopharma (RDHL) has reported Asset Utilization Ratio for 11 consecutive years, with 0.76 the latest figure, recorded in Q2 2023.

• On a quarterly basis, Asset Utilization Ratio rose 69.8% year-over-year to 0.76 in Q2 2023; TTM through Jun 2023 was 0.76, a 69.8% increase from a year earlier, with the FY2025 full-year figure at 0.01, down 96.63% from the prior year.
• Asset Utilization Ratio was 0.76 for Q2 2023 at RedHill Biopharma, up from 0.48 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.76 in Q2 2023 and troughed at 0.05 in Q1 2020.
• A 5-year average of 0.34 and a median of 0.39 in 2021 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio tumbled 59.38% in 2020 and jumped 712.54% in 2021, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.11 in 2019, then soared by 234.97% to 0.37 in 2020, then climbed by 26.61% to 0.47 in 2021, then retreated by 16.2% to 0.39 in 2022, then soared by 94.75% to 0.76 in 2023.
• The last three Asset Utilization Ratio figures came in at 0.76 (Q2 2023), 0.48 (Q1 2023), and 0.39 (Q4 2022), per Business Quant data.